These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29471305)

  • 1. Humanized Exposures of Cefiderocol, a Siderophore Cephalosporin, Display Sustained in vivo Activity against Siderophore-Resistant Pseudomonas aeruginosa.
    Ghazi IM; Monogue ML; Tsuji M; Nicolau DP
    Pharmacology; 2018; 101(5-6):278-284. PubMed ID: 29471305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model.
    Monogue ML; Tsuji M; Yamano Y; Echols R; Nicolau DP
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model.
    Ghazi IM; Monogue ML; Tsuji M; Nicolau DP
    Int J Antimicrob Agents; 2018 Feb; 51(2):206-212. PubMed ID: 29111435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Humanized Cefiderocol Exposure Is Unaltered by Host Iron Overload in the Thigh Infection Model.
    Kidd JM; Abdelraouf K; Nicolau DP
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015.
    Karlowsky JA; Hackel MA; Tsuji M; Yamano Y; Echols R; Sahm DF
    Int J Antimicrob Agents; 2019 Apr; 53(4):456-466. PubMed ID: 30471402
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Nakamura R; Ito-Horiyama T; Takemura M; Toba S; Matsumoto S; Ikehara T; Tsuji M; Sato T; Yamano Y
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy.
    Kim A; Kutschke A; Ehmann DE; Patey SA; Crandon JL; Gorseth E; Miller AA; McLaughlin RE; Blinn CM; Chen A; Nayar AS; Dangel B; Tsai AS; Rooney MT; Murphy-Benenato KE; Eakin AE; Nicolau DP
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7743-52. PubMed ID: 26438502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emergence of cefiderocol resistance in
    Teran N; Egge SL; Phe K; Baptista RP; Tam VH; Miller WR
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0100923. PubMed ID: 38063509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens.
    Oh SH; Park HS; Kim HS; Yun JY; Oh K; Cho YL; Kwak JH
    Int J Antimicrob Agents; 2017 Dec; 50(6):700-706. PubMed ID: 28668680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa.
    Ito A; Nishikawa T; Matsumoto S; Yoshizawa H; Sato T; Nakamura R; Tsuji M; Yamano Y
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7396-7401. PubMed ID: 27736756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of antibacterial activity of the MB-1 siderophore-monobactam conjugate using an efflux pump inhibitor.
    Tomaras AP; Crandon JL; McPherson CJ; Nicolau DP
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2439-42. PubMed ID: 25605364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units.
    Golden AR; Adam HJ; Baxter M; Walkty A; Lagacé-Wiens P; Karlowsky JA; Zhanel GG
    Diagn Microbiol Infect Dis; 2020 May; 97(1):115012. PubMed ID: 32081522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design.
    Huband MD; Ito A; Tsuji M; Sader HS; Fedler KA; Flamm RK
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):198-200. PubMed ID: 28410852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa.
    Tomaras AP; Crandon JL; McPherson CJ; Banevicius MA; Finegan SM; Irvine RL; Brown MF; O'Donnell JP; Nicolau DP
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4197-207. PubMed ID: 23774440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefiderocol: A Siderophore Cephalosporin.
    El-Lababidi RM; Rizk JG
    Ann Pharmacother; 2020 Dec; 54(12):1215-1231. PubMed ID: 32522005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefiderocol (S-649266), A new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: Structure activity relationship.
    Aoki T; Yoshizawa H; Yamawaki K; Yokoo K; Sato J; Hisakawa S; Hasegawa Y; Kusano H; Sano M; Sugimoto H; Nishitani Y; Sato T; Tsuji M; Nakamura R; Nishikawa T; Yamano Y
    Eur J Med Chem; 2018 Jul; 155():847-868. PubMed ID: 29960205
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Mushtaq S; Sadouki Z; Vickers A; Livermore DM; Woodford N
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Humanized Cefiderocol Exposures over 72 Hours against a Diverse Group of Gram-Negative Isolates in the Neutropenic Murine Thigh Infection Model.
    Stainton SM; Monogue ML; Tsuji M; Yamano Y; Echols R; Nicolau DP
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30420477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens.
    Dobias J; Dénervaud-Tendon V; Poirel L; Nordmann P
    Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2319-2327. PubMed ID: 28748397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefiderocol: a novel siderophore cephalosporin.
    Choi JJ; McCarthy MW
    Expert Opin Investig Drugs; 2018 Feb; 27(2):193-197. PubMed ID: 29318906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.